"In our opinion there's no sufficient evidence to this hypothesis and more than ever there's no cause for wanting to have the supposed vascular blockage removed in a so-called Liberation Treatment for several thousand euros."
1eye wrote:It seems easy to throw cold water on something that has had better success than 150 years of neurological bungling when you have no symptoms yourself.
I think you hit the hammer right on your head. Dr. Hartung's press release belongs on an internet forum. That it heralds a presentation to be made at a scientific convention leads one to expect that the presentation will likewise be an emotionally-laden hatchet piece.scorpion wrote:Oh the nerve of Dr. Hartung . I will agree that spewing out mud and misinformation deserves a response which is why I post on this forum quite often.
cah wrote:Found the schedule of the press conferences: http://www.dgn.org/pressekonferenzen.html
One is held on Sept 21 by Dr. Steinmetz between 12 and 13 h, title:
"Quality management: Neurologists criticise dangerous vascular surgeries in MS"
concerned wrote:Lyon- It's simple. Anyone who has any dealing with medical/pharmaceutical companies is bad unless they are CCSVI docs, like the people on Zamboni's team who receive monies from Biogen and Teva, two companies who really are dependent on DMD sales. That's not a conflict of interests because it is in the interests of the CCSVI racket.
Direct-MS wrote:Hartung is on-the-take from the pharmaceutical companies big time. Here is the tip of the iceberg regarding the drug money this guy brings home. I suppose one can't blame him for trashing CCSVI given he probably brings in over a million dollars a year of drug company money. As I mentioned in another post, the massive corruption of the neurological community, with compromised guys like Hartung being a great example of such corruption, is very harmful to PwMS.
H. P. Hartung has received honoraria from Bayer HealthCare, Biogen Idec, BioMS Genzyme, Merck Serono, Novartis, Sanofi Aventis and Teva for lectures. was paid travel/accomodation expenses covered or reimbursed by Biogen Idec, Novartis Pharma.
He has also received research funding from Bayer HealthCare, Biogen Idec, Merck Serono, Novartis, Sanofi Aventis and Teva
cah wrote:I know the conflicts of interest from Dr. Hartung. The question is, now that this text above is published in about every german online newspaper, what can be done about that?
Users browsing this forum: No registered users